In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.
Captain Casey Barton Behravesh of the U.S. Public Health Service, and Director of the CDC One Health Office highlights the CDC’s efforts to nationally and internationally prevent zoonotic diseases.
With 7.5 million people living with HIV, how has climate change and COVID-19 affected the South African governments control over the AIDS crisis and which demographics have been hit the hardest?
The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.
Mary Bright, Head of Social Affairs and Age Special Adviser at Phoenix Group, explains why tackling ‘care phobia’ is the key to unlocking health and wealth in later life.
Now that we are living in a country that is largely free from Coronavirus restrictions, will Test & Trace remain part of our new normal? Rhian Gorecki, Research Manager at Walnut UNLIMITED explores here.
Rowan Pritchard Jones, Medical Director at St Helens and Knowsley Teaching Hospitals NHS Trust, discusses how telehealth has helped the hospital support its patients during COVID and beyond.
Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, offers preliminary context about the impact of the COVID-19 pandemic in most African countries, starting with lessons to be learned from previous outbreaks.
Mike Smith, Director Large Enterprise & Public Sector at Virgin Media 02 Business, focuses our thoughts on achieving interoperability and driving the digital rebound in healthcare.
Dr Reddy, Dentist at Harley Street Specialist Hospital, explains why it’s important to promote oral health and provide optimal dental care in Europe today.
Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.
Dr Quinton Fivelman, PhD, Chief Scientific Officer at London Medical Laboratory, reveals that antibody levels for the double-jabbed are now waning. He asks was the UK Government unwise to relax most COVID precautions in July?.
Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.
Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.
